Last reviewed · How we verify

Ibuprofen + Pseudoephedrine Hydrochloride

Dr. Reddy's Laboratories Limited · FDA-approved active Small molecule

Ibuprofen + Pseudoephedrine Hydrochloride is a NSAID + decongestant combination Small molecule drug developed by Dr. Reddy's Laboratories Limited. It is currently FDA-approved for Relief of pain, fever, and nasal congestion associated with common cold and flu. Also known as: Advil® Cold and Sinus.

Ibuprofen reduces inflammation and pain by inhibiting cyclooxygenase enzymes, while pseudoephedrine constricts blood vessels in the nasal passages to relieve congestion.

Ibuprofen reduces inflammation and pain by inhibiting cyclooxygenase enzymes, while pseudoephedrine constricts blood vessels in the nasal passages to relieve congestion. Used for Relief of pain, fever, and nasal congestion associated with common cold and flu.

At a glance

Generic nameIbuprofen + Pseudoephedrine Hydrochloride
Also known asAdvil® Cold and Sinus
SponsorDr. Reddy's Laboratories Limited
Drug classNSAID + decongestant combination
TargetCOX-1/COX-2 (ibuprofen); alpha-adrenergic receptors (pseudoephedrine)
ModalitySmall molecule
Therapeutic areaPain Management / Cold & Flu Symptom Relief
PhaseFDA-approved

Mechanism of action

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that blocks COX-1 and COX-2 enzymes, thereby reducing prostaglandin synthesis and decreasing inflammation, pain, and fever. Pseudoephedrine is a sympathomimetic amine that acts as an alpha-adrenergic agonist, causing vasoconstriction in nasal blood vessels to reduce swelling and nasal congestion. This combination provides dual symptomatic relief for cold and flu symptoms.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Ibuprofen + Pseudoephedrine Hydrochloride

What is Ibuprofen + Pseudoephedrine Hydrochloride?

Ibuprofen + Pseudoephedrine Hydrochloride is a NSAID + decongestant combination drug developed by Dr. Reddy's Laboratories Limited, indicated for Relief of pain, fever, and nasal congestion associated with common cold and flu.

How does Ibuprofen + Pseudoephedrine Hydrochloride work?

Ibuprofen reduces inflammation and pain by inhibiting cyclooxygenase enzymes, while pseudoephedrine constricts blood vessels in the nasal passages to relieve congestion.

What is Ibuprofen + Pseudoephedrine Hydrochloride used for?

Ibuprofen + Pseudoephedrine Hydrochloride is indicated for Relief of pain, fever, and nasal congestion associated with common cold and flu.

Who makes Ibuprofen + Pseudoephedrine Hydrochloride?

Ibuprofen + Pseudoephedrine Hydrochloride is developed and marketed by Dr. Reddy's Laboratories Limited (see full Dr. Reddy's Laboratories Limited pipeline at /company/dr-reddy-s-laboratories-limited).

Is Ibuprofen + Pseudoephedrine Hydrochloride also known as anything else?

Ibuprofen + Pseudoephedrine Hydrochloride is also known as Advil® Cold and Sinus.

What drug class is Ibuprofen + Pseudoephedrine Hydrochloride in?

Ibuprofen + Pseudoephedrine Hydrochloride belongs to the NSAID + decongestant combination class. See all NSAID + decongestant combination drugs at /class/nsaid-decongestant-combination.

What development phase is Ibuprofen + Pseudoephedrine Hydrochloride in?

Ibuprofen + Pseudoephedrine Hydrochloride is FDA-approved (marketed).

What are the side effects of Ibuprofen + Pseudoephedrine Hydrochloride?

Common side effects of Ibuprofen + Pseudoephedrine Hydrochloride include Gastrointestinal upset (nausea, dyspepsia), Headache, Dizziness, Nervousness or insomnia, Tachycardia.

What does Ibuprofen + Pseudoephedrine Hydrochloride target?

Ibuprofen + Pseudoephedrine Hydrochloride targets COX-1/COX-2 (ibuprofen); alpha-adrenergic receptors (pseudoephedrine) and is a NSAID + decongestant combination.

Related